These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 2376047)
1. Major-histocompatibility-complex-class-II-positive cells and interleukin-2-dependent proliferation of immune T cells are required to reject carcinoma cells in the guinea pig. Steerenberg PA; De Jong WH; Geerse E; Beuvink A; Scheper RJ; Den Otter W; Ruitenberg EJ Cancer Immunol Immunother; 1990; 31(5):297-304. PubMed ID: 2376047 [TBL] [Abstract][Full Text] [Related]
2. Tumour rejection after adoptive transfer of line-10-immune spleen cells is mediated by two T cell subpopulations. Steerenberg PA; Geerse E; De Jong WH; Burger R; Scheper RJ; Den Otter W Cancer Immunol Immunother; 1991; 34(2):103-10. PubMed ID: 1760813 [TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II antigen expression during potentiation of line-10 tumor immunity after intralesional administration of bacillus Calmette-Guérin. Steerenberg PA; De Jong WH; Geerse E; Aleva BJ; Besselink CM; Van Rens BT; Rutten VP; Poels LG; Scheper RJ; Den Otter W Cancer Immunol Immunother; 1990; 32(2):95-104. PubMed ID: 1963114 [TBL] [Abstract][Full Text] [Related]
4. Major histocompatibility complex class II antigen expression on leucocyte subpopulations in the draining lymph node and tumour in the early phase of bacillus-Calmette-Guérin-induced tumour regression. Steerenberg PA; De Jong WH; Geerse E; De Graaf A; Scheper RJ; Den Otter W; Ruitenberg EJ Cancer Immunol Immunother; 1991; 33(3):189-97. PubMed ID: 1828389 [TBL] [Abstract][Full Text] [Related]
5. Impact of 15-deoxyspergualin on effector cells in experimental autoimmune diseases of the nervous system in the Lewis rat. Jung S; Toyka KV; Hartung HP Clin Exp Immunol; 1994 Dec; 98(3):494-502. PubMed ID: 7527745 [TBL] [Abstract][Full Text] [Related]
6. Analysis of T-T lymphocytes and T-accessory cell interactions using cloned T cells: MHC I restricted cloned T cells activate MHC II restricted T helper cells. Brückner T; Di Pauli R Cell Immunol; 1986 Apr; 99(1):182-95. PubMed ID: 2875800 [TBL] [Abstract][Full Text] [Related]
7. Selective localization of tumor-immune spleen cells at the tumor challenge site after adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs. de Jong WH; van de Plas MM; Steerenberg PA; Kruizinga W; Ruitenberg EJ J Immunol; 1985 Mar; 134(3):2032-40. PubMed ID: 2578526 [TBL] [Abstract][Full Text] [Related]
8. Tumour-specific CTL response requiring interactions of four different cell types and recognition of MHC class I and class II restricted tumour antigens. Schirrmacher V; Schild HJ; Gückel B; von Hoegen P Immunol Cell Biol; 1993 Aug; 71 ( Pt 4)():311-26. PubMed ID: 7901150 [TBL] [Abstract][Full Text] [Related]
9. T-cell involvement in adoptive transfer of line 10 tumor immunity in strain 2 guinea pigs. de Jong WH; Steerenberg PA; van de Plas MM; Kruizinga W; Ruitenberg J J Natl Cancer Inst; 1985 Sep; 75(3):483-9. PubMed ID: 3875751 [TBL] [Abstract][Full Text] [Related]
10. Identification of a membrane antigen that is distinct from the interleukin 2 receptor and that may be required for interleukin 2-driven proliferative responses. Malek TR; Robb RJ; Shevach EM J Immunol; 1983 Feb; 130(2):747-55. PubMed ID: 6184403 [TBL] [Abstract][Full Text] [Related]
11. Locoregional therapy with polyethylene-glycol-modified interleukin-2 of an intradermally growing hepatocellular carcinoma in the guinea pig induces T-cell-mediated antitumor activity. Balemans LT; Mattijssen V; Steerenberg PA; Van Driel BE; De Mulder PH; Den Otter W Cancer Immunol Immunother; 1993 Jul; 37(1):7-14. PubMed ID: 8513455 [TBL] [Abstract][Full Text] [Related]
12. Antitumour activity mediated by CD4+ cytotoxic T lymphocytes against MHC class II-negative mouse hepatocellular carcinoma induced by dendritic cell vaccine and interleukin-12. Homma S; Komita H; Sagawa Y; Ohno T; Toda G Immunology; 2005 Aug; 115(4):451-61. PubMed ID: 16011514 [TBL] [Abstract][Full Text] [Related]
13. T-cell activation. IV. Evidence for a functional linkage between MHC class I, interleukin-2 receptor, and interleukin-4 receptor molecules. Hansen NQ; Tscherning T; Claesson MH Cytokine; 1991 Jan; 3(1):35-41. PubMed ID: 1832052 [TBL] [Abstract][Full Text] [Related]
14. Characterization of two distinct primary T cell populations that secrete interleukin 2 upon recognition of class I or class II major histocompatibility antigens. Mizuochi T; Ono S; Malek TR; Singer A J Exp Med; 1986 Mar; 163(3):603-19. PubMed ID: 2936862 [TBL] [Abstract][Full Text] [Related]
15. Mechanisms of immunological eradication of a syngeneic guinea pig tumor. II. Effect of methotrexate treatment and T cell depletion of the recipient on adoptive immunity. Shu S; Fonseca LS; Hunter JT; Rapp HJ Transplantation; 1983 Jan; 35(1):56-61. PubMed ID: 6297130 [TBL] [Abstract][Full Text] [Related]
16. Specific tumor memory induced by polyethylene-glycol-modified interleukin-2 requires both helper and cytotoxic T cells. Balemans LT; Steerenberg PA; Kremer BH; Koppenhagen FJ; De Mulder PH; Den Otter W Cancer Immunol Immunother; 1995 Feb; 40(2):125-31. PubMed ID: 7882383 [TBL] [Abstract][Full Text] [Related]
17. The natural immune response to inhaled soluble protein antigens involves major histocompatibility complex (MHC) class I-restricted CD8+ T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective suppression of immunoglobulin E production. McMenamin C; Holt PG J Exp Med; 1993 Sep; 178(3):889-99. PubMed ID: 8102390 [TBL] [Abstract][Full Text] [Related]
18. CD4-CD8- T cell receptor alpha beta T cells: generation of an in vitro major histocompatibility complex class I specific cytotoxic T lymphocyte response and allogeneic tumor rejection. Mieno M; Suto R; Obata Y; Udono H; Takahashi T; Shiku H; Nakayama E J Exp Med; 1991 Jul; 174(1):193-201. PubMed ID: 1905338 [TBL] [Abstract][Full Text] [Related]
19. Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions. Shu S; Steerenberg PA; Hunter JT; Evans CH; Rapp HJ Cancer Res; 1981 Sep; 41(9 Pt 1):3499-506. PubMed ID: 7260913 [TBL] [Abstract][Full Text] [Related]
20. The rejection mechanism of rat pancreaticoduodenal allografts with a class I MHC disparity. Yamamoto S; Ito T; Nakata S; Nozaki S; Uchikoshi F; Shirakura R; Kamiike W; Miyata M; Matsuda H Transplantation; 1994 Apr; 57(8):1217-22. PubMed ID: 7909966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]